Unknown

Dataset Information

0

Structural basis for inhibition of the Cation-chloride cotransporter NKCC1 by the diuretic drug bumetanide.


ABSTRACT: Cation-chloride cotransporters (CCCs) NKCC1 and NKCC2 catalyze electroneutral symport of 1 Na+, 1 K+, and 2 Cl- across cell membranes. NKCC1 mediates trans-epithelial Cl- secretion and regulates excitability of some neurons and NKCC2 is critical to renal salt reabsorption. Both transporters are inhibited by the so-called loop diuretics including bumetanide, and these drugs are a mainstay for treating edema and hypertension. Here, our single-particle electron cryo-microscopy structures supported by functional studies reveal an outward-facing conformation of NKCC1, showing bumetanide wedged into a pocket in the extracellular ion translocation pathway. Based on these and the previously published inward-facing structures, we define the translocation pathway and the conformational changes necessary for ion translocation. We also identify an NKCC1 dimer with separated transmembrane domains and extensive transmembrane and C-terminal domain interactions. We further define an N-terminal phosphoregulatory domain that interacts with the C-terminal domain, suggesting a mechanism whereby (de)phosphorylation regulates NKCC1 by tuning the strength of this domain association.

SUBMITTER: Zhao Y 

PROVIDER: S-EPMC9117670 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structural basis for inhibition of the Cation-chloride cotransporter NKCC1 by the diuretic drug bumetanide.

Zhao Yongxiang Y   Roy Kasturi K   Vidossich Pietro P   Cancedda Laura L   De Vivo Marco M   Forbush Biff B   Cao Erhu E  

Nature communications 20220518 1


Cation-chloride cotransporters (CCCs) NKCC1 and NKCC2 catalyze electroneutral symport of 1 Na<sup>+</sup>, 1 K<sup>+</sup>, and 2 Cl<sup>-</sup> across cell membranes. NKCC1 mediates trans-epithelial Cl<sup>-</sup> secretion and regulates excitability of some neurons and NKCC2 is critical to renal salt reabsorption. Both transporters are inhibited by the so-called loop diuretics including bumetanide, and these drugs are a mainstay for treating edema and hypertension. Here, our single-particle el  ...[more]

Similar Datasets

| S-EPMC11876703 | biostudies-literature
| S-EPMC6856059 | biostudies-literature
| S-EPMC10786066 | biostudies-literature
| S-EPMC7035313 | biostudies-literature
| S-EPMC2865971 | biostudies-literature
| S-EPMC9640557 | biostudies-literature
| S-EPMC9920462 | biostudies-literature
| EMPIAR-12539 | biostudies-other
| S-EPMC8294628 | biostudies-literature
| S-EPMC11324901 | biostudies-literature